Free Trial

Oxford BioDynamics (OBD) Stock Forecast & Price Target

GBX 6.30
-0.02 (-0.32%)
(As of 06:00 AM ET)

Oxford BioDynamics - Analysts' Recommendations and Stock Price Forecast (2024)

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Consensus Rating

Consensus Price Target

N/A

TypeCurrent Forecast
6/20/23 to 6/19/24
1 Month Ago
5/21/23 to 5/20/24
3 Months Ago
3/22/23 to 3/21/24
1 Year Ago
6/20/22 to 6/20/23
Consensus RatingN/AN/AN/AN/A
Strong Buy N/A N/A N/A N/A
Buy N/A N/A N/A N/A
Hold N/A N/A N/A N/A
Sell N/A N/A N/A N/A
Consensus Price TargetN/AN/AN/AN/A
Get Oxford BioDynamics Upgrade and Downgrade Alerts

Sign-up to receive the latest news and ratings for OBD and its competitors with MarketBeat's FREE daily newsletter.

OBD Analyst Recommendations By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.
Skip Chart & View Analyst Rating History

OBD Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.
Skip Chart and View Analyst Price Target HistorySkip Chart & View Price History Table

Oxford BioDynamics Stock vs. The Competition

TypeOxford BioDynamicsMedical Companies
Consensus Rating Score
0.00
2.70
Consensus RatingN/AModerate Buy
News Sentiment RatingNeutral News
Positive News
DateBrokerageAnalyst NameActionRatingPrice TargetUpside/Downside on Report DateDetails
6/18/2024Shore Capital
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Reiterated RatingHouse Stock

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Wednesday at 06:19 AM ET.

OBD Forecast - Frequently Asked Questions

What analysts cover Oxford BioDynamics?

Oxford BioDynamics has been rated by research analysts at Shore Capital in the past 90 days.


Stock Forecasts and Research Tools

This page (LON:OBD) was last updated on 6/19/2024 by MarketBeat.com Staff

From Our Partners